GP100060
IFNα2b(102-108)-Tn(105)
Synthetic glycopeptide fragment of Interferon alpha 2b, IFNα2b, marketed for therapeutic use as Intron-A®. The peptide sequence VGVTETP corresponds to positions 103-109 of the mature IFNα2b protein with α-GalNAc glycosylation (Tn Antigen) ocurring at Thr105. The C-terminus is an amide.
Sequence:
VGVT*ETP-NH2
H-Val-Gly-Val-Thr*-Glu-Thr-Pro-NH2
where T* = Thr* = GalNAcα-O-Thr
IFNα2b(102-108)-Tn(105)
Synthetic glycopeptide fragment of Interferon alpha 2b, IFNα2b, marketed for therapeutic use as Intron-A®. The peptide sequence VGVTETP corresponds to positions 103-109 of the mature IFNα2b protein with α-GalNAc glycosylation (Tn Antigen) ocurring at Thr105. The C-terminus is an amide.
Sequence:
VGVT*ETP-NH2
H-Val-Gly-Val-Thr*-Glu-Thr-Pro-NH2
where T* = Thr* = GalNAcα-O-Thr
$375.00 USD
- For research and development use only
-
Other Names
Interferon alpha IFNα2b(Tn) glycopeptide
-
Technical Data
UniProt ID: Q6QNB6
Formula: C44H71N9O19
Molecular Weight: 903.97
Purity: >90% (HPLC)
-
Storage & Shipping
Shipping requirement: Dry Ice
Storage conditions: -20°C